TCL Archive In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List December 2, 1983
TCL Archive NCI Accused Of forsaking Its Mission In House Hearing On Screening Statement March 18, 1994
TCL Archive Practice of Oncology Must Incorporate Clinical Research, NCI Director Tells ASCO May 30, 1997